Debt Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2022-06
ALKERMES USD 291.37M 635K 2023-09
BioCryst Pharmaceuticals USD 833.18M 13.88M 2023-09
Biogen USD 6.94B 348.2M 2023-12
Bristol-Myers Squibb USD 39.77B 2.17B 2023-12
Cytokinetics USD 618.45M 9.43M 2023-12
Esperion Therapeutics USD 261.16M 427K 2023-09
Gilead Sciences USD 24.98B 264M 2023-09
Halozyme Therapeutics USD 1.5B 1.63M 2023-12
Intra Cellular Therapies USD 0 0 2022-06
J&J USD 29.92B 15.68B 2023-09
Marinus Pharmaceuticals USD 72.48M 497K 2023-09
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 169.9M 200K 2023-09
Prothena USD 0 0 2022-06
RedHill Biopharma USD 2.28M 4.71M 2023-06
Supernus Pharmaceuticals USD 480.86M 78.9M 2023-03
United Therapeutics USD 700M 100M 2023-12



Intra Cellular Therapies DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.